Difference between revisions of "Thyroid Disease"
m (→Unacceptable) |
JoseRosSoto (talk | contribs) m (→Acceptable) |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 24: | Line 24: | ||
====Acceptable==== | ====Acceptable==== | ||
| − | Hypothyroid (including Hashimoto thyroiditis) and stable on thyroid replacement therapy; | + | Hypothyroid (including Hashimoto thyroiditis) and stable for at least three months on thyroid replacement therapy; |
Benign thyroid tumour (e.g. oncocytoma); | Benign thyroid tumour (e.g. oncocytoma); | ||
| Line 30: | Line 30: | ||
If in doubt, discuss with medical officer. | If in doubt, discuss with medical officer. | ||
| − | |||
| − | |||
==Pseudonyms or Related Conditions== | ==Pseudonyms or Related Conditions== | ||
| Line 49: | Line 47: | ||
==Version== | ==Version== | ||
| − | Version 1, Edition | + | Version 1, Edition 2 |
====Date of Last Update==== | ====Date of Last Update==== | ||
| − | + | 1 June 2016 | |
Latest revision as of 17:17, 24 September 2018
Contents
Acceptability at Recruitment
QUALIFIED
Acceptability at CT / Work-Up
QUALIFIED
Individual at Risk
Donor / Recipient
Explanation of Condition
The thyroid gland produces thyroxine, which controls the body's rate of metabolism.
Guidance
Unacceptable
Malignant (cancerous);
Any thyroid disorder under investigation;
Graves disease (hyperthyroidism or thyrotoxicosis) within six months of treatment with radioactive iodine therapy;
Graves disease (hyperthyroidism or thyrotoxicosis) within 2 years of completing anti-thyroid tablet therapy (e.g. carbimazole);
Currently taking beta-blockers;
Acceptable
Hypothyroid (including Hashimoto thyroiditis) and stable for at least three months on thyroid replacement therapy;
Benign thyroid tumour (e.g. oncocytoma);
If in doubt, discuss with medical officer.
Pseudonyms or Related Conditions
Hypothyroidism
Hyperthyroidism
Hashimoto thyroiditis
Thyrotoxicosis
Graves disease/thyroiditis
Thyroid carcinoma
Oncocytoma of thyroid,
Version
Version 1, Edition 2
Date of Last Update
1 June 2016
